雷公藤甲素联合顺铂对人宫颈癌顺铂耐药细胞株Hela/DDP生长、凋亡及侵袭的影响

Effects of triptolide combined with cisplatin on growth,apoptosis and invasion of human cervical cancer cell cisplatin-resistance line Hela/DDP

  • 摘要: 目的 研究雷公藤甲素(triptolide,TP)联合顺铂对宫颈癌Hela/DDP细胞株生长、凋亡及侵袭的影响及机制。方法 将Hela/DDP细胞随机分为对照组、顺铂组(100 mg/ml)、雷公藤甲素组(80 nmol/L)及联合组(100 mg/ml顺铂+80 nmol/L雷公藤甲素),CCK-8法检测各组细胞的生长情况,流式细胞术检测各组细胞凋亡率,Transwell检测细胞侵袭能力,Western blot法检测各组凋亡相关蛋白Bcl-2、FLIP、XIAP的表达。结果 雷公藤甲素能抑制宫颈癌顺铂耐药细胞株Hela/DDP增殖,并促进细胞凋亡,降低细胞侵袭能力(空白对照组、顺铂组、雷公藤甲素组、联合组细胞抑制率分别为0、(21.68±3.40)%、(32.60±5.21)%、(58.11±3.59)%,凋亡率分别为(2.87±0.63)%、(15.16±1.13)%、(21.66±1.46)%、(33.35±0.93)%,穿过Transwell小室的细胞数分别为304.33±17.21、271.67±7.51、261.67±5.69、196.00±14.93),与顺铂组相比,联合组对细胞有明显的抑制作用(P<0.05)。分子水平上,各组Bcl-2蛋白表达量分别为1.05±0.08、0.86±0.05、0.75±0.13、0.57±0.11,XIAP蛋白表达量分别为1.05±0.06、0.68±0.01、0.67±0.03、0.38±0.02,FLIP蛋白表达量分别为0.72±0.27、0.54±0.02、0.41±0.07、0.35±0.03,与空白对照组相比,顺铂组、雷公藤甲素组和联合组的Bcl-2、XIAP蛋白的表达水平降低(P<0.05),雷公藤甲素组和联合组FLIP蛋白的表达水平降低(P<0.05)。结论 雷公藤甲素联合顺铂能协同抑制Hela/DDP细胞生长并诱导细胞凋亡,降低Hela/DDP细胞对顺铂的耐药性,其分子机制可能与下调Bcl-2、FLIP、XIAP蛋白的表达相关。

     

    Abstract: Objective To investigate the effects of triptolide combined with cisplatin on the growth,apoptosis and invasion of Hela/DDP cell lines of cervical cancer and its mechanism. Methods Hela/DDP cells were randomly divided into control group,platinum group (100 mg/ml),triptolide group (80 nmol/L) and combined group (100 mg/ml DDP and 80 nmol/l triptolide).The growth rate of each group was detected by CCK-8 assay,the apoptosis rate of each group was detected by flow cytometry,the cell invasion ability was detected by Transwell chamber technology,and expression of apoptosis-related protein Bcl-2,FLIP,XIAP was detected by Western blot. Results Triptolide could inhibit the proliferation of cisplatin resistance cell line Hela/DDP,promote cell apoptosis and reduce the ability of cell invasion (The cell inhibition rates of blank control group,cisplatin group,triptolide group and combined group were 0,21.68±3.40%,32.60±5.21%,58.11±3.59%,the apoptosis rates were 2.87±0.63%,15.16±1.13%,21.66±1.46%,33.35±0.93%,and the number of cells passing the Transwell chamber were 304.33±17.21,271.67±7.51,261.67±5.69,196.00±14.93).Compared to DDP treatment,combination of DDP and TP had a significant inhibition effect (P<0.05).At the molecular level,the expression of Bcl-2 protein in blank control group,cisplatin group,Triptolide group and combined group were 1.05±0.08,0.86±0.05,0.75±0.13,0.57±0.11,the expression of XIAP were 1.05±0.06,0.68±0.01,0.67±0.03,0.38±0.02,the expression of FLIP were 0.72±0.27,0.54±0.02,0.41±0.07,0.35±0.03.Compared to blank control group,the expression of Bcl-2 and XIAP protein decreased significantly in cisplatin group,triptolide group and combined group (all P<0.05),and the expression of FLIP protein in Triptolide group and combination group also decreased significantly (all P<0.05). Conclusion The combination of triptolide and cisplatin can inhibit the growth of Hela/ DDP cells and induce cell apoptosis and reduce the resistance of Hela/DDP cells to cisplatin,and its molecular mechanism may be related to the down-regulation of the expression of Bcl-2,FLIP,XIAP protein.

     

/

返回文章
返回